Showing results (1421-1430 of 1,998) with videos related to

Sort By:
Pageof 200
Clinical Pharmacology and Therapeutics|December 2, 1998
Metabolism of ropivacaine in humans is mediated by CYP1A2 and to a minor extent by CYP3A4: an interaction study with fluvoxamine and ketoconazole as in vivo inhibitorsE Arlander, G Ekström, C Alm, et al.
Neurology. Genetics|January 22, 2025
Acute Vestibular Syndrome Unmasking an RFC1-Spectrum DisorderLuca Verrecchia, Victor Alm, Håkan Thonberg, et al.
Research in Developmental Disabilities|September 12, 2013
Impaired implicit sequence learning in children with developmental dyslexiaMartina Hedenius, Jonas Persson, Per A Alm, et al.
Cancer Treatment Reports|November 1, 1986
Treatment of malignant carcinoid tumors with human leukocyte interferon: long-term resultsK Oberg, I Norheim, E Lind, et al.
Plos One|May 21, 2019
Aerodigestive sampling reveals altered microbial exchange between lung, oropharyngeal, and gastric microbiomes in children with impaired swallow functionClaire Duvallet, Kara Larson, Scott Snapper, et al.
European Psychiatry : the Journal of the Association of European Psychiatrists|November 21, 2007
Subtype differences in adults with attention-deficit/hyperactivity disorder (ADHD) with regard to ADHD-symptoms, psychiatric comorbidity and psychosocial adjustmentEsther Sobanski, Daniel Brüggemann, Barbara Alm, et al.
Pharmaceutical Biology|October 8, 2014
Ameliorative effect of propolis against cyclophosphamide-induced toxicity in miceSabry A El-Naggar, Abeer A Alm-Eldeen, Mousa O Germoush, et al.
Pediatrics|October 2, 1997
Combined effects of sleeping position and prenatal risk factors in sudden infant death syndrome: the Nordic Epidemiological SIDS StudyN Oyen, T Markestad, R Skaerven, et al.
The Journal of Prevention of Alzheimer'S Disease|January 6, 2026
Hippocampal microstructure as a measure of cognitive resilience to tau PET burden in older adultsDaniel D Callow, Nisha Rani, Kylie H Alm, et al.
Advances in Medical Sciences|September 10, 2025
Ropivacaine and lidocaine at clinically relevant concentrations suppress proliferation and migration of ovarian cancer cells and induce morphological alterationsJane M Hayden, Andreas Tinnert, Kersti Alm, et al.
Pageof 200